Endocrinology, Vol 136, 2513-2520, Copyright © 1995 by Endocrine Society

ARTICLES

Cyclic adenosine monophosphate (cAMP) analogs 8-Cl- and 8-NH2-cAMP induce cell death independently of cAMP kinase-mediated inhibition of the G1/S transition in mammary carcinoma cells (MCF-7)

OK Vintermyr, R Boe, OT Brustugun, E Maronde, A Aakvaag and SO Doskeland
Department of Anatomy and Cell Biology, University of Bergen, Norway.

Human mammary carcinoma cells (MCF-7) were arrested in late G1-phase after treatment with agents (forskolin, interleukin-1 beta 3-isobutyl-1- methylxanthine) that increased the endogenous concentrations of cAMP. The effect of elevated cAMP was mimicked by microinjected catalytic (C alpha) cAMP-dependent protein kinase (cAK) subunit and reversed by the injection of a dominant negative cAK regulatory mutant (RID199). Further evidence that activation of cAK induced growth arrest was provided by the use of pairs of stable cAMP analogs known to synergistically activate isolated cAK isozymes. Furthermore, the effect of cAMP was not potentiated by serine/threonine phosphatase inhibitors that profoundly restricted MCF-7 growth. Some 8-substituted cAMP analogs, e.g. 8-Cl-cAMP and 8-NH2-cAMP, induced cell death rather than reversible inhibition of growth. Their effect was not synergized with complementary cAMP analogs. Furthermore, their potency was decreased rather than increased in the presence of an inhibitor of degradation (3- isobutyl-1-methylxanthine). Finally, their effect could be mimicked by degradation products unable to activate cAK. We concluded that 8-Cl- cAMP (and 8-NH2-cAMP) induced irreversible growth arrest by a mechanism not involving cAK, whereas activation of cAK resulted in a transient and fully reversible inhibition of cell proliferation.

This article has been cited by other articles:

				K. Ghias, C. Ma, V. Gandhi, L. C. Platanias, N. L. Krett, and S. T. Rosen 8-Amino-adenosine induces loss of phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Akt kinase: Role in induction of apoptosis in multiple myeloma Mol. Cancer Ther., April 1, 2005; 4(4): 569 - 577. [Abstract] [Full Text] [PDF]

				N. L. Krett, K. M. Davies, M. Ayres, C. Ma, C. Nabhan, V. Gandhi, and S. T. Rosen 8-Amino-adenosine is a potential therapeutic agent for multiple myeloma Mol. Cancer Ther., November 1, 2004; 3(11): 1411 - 1420. [Abstract] [Full Text] [PDF]

				S. Monno, M. V. Newman, M. Cook, and W. L. Lowe Jr. Insulin-Like Growth Factor I Activates c-Jun N-Terminal Kinase in MCF-7 Breast Cancer Cells Endocrinology, February 1, 2000; 141(2): 544 - 550. [Abstract] [Full Text] [PDF]

				R. G. Halgren, A. E. Traynor, S. Pillay, J. L. Zell, K. F. Heller, N. L. Krett, and S. T. Rosen 8Cl-cAMP Cytotoxicity in Both Steroid Sensitive and Insensitive Multiple Myeloma Cell Lines Is Mediated by 8Cl-Adenosine Blood, October 15, 1998; 92(8): 2893 - 2898. [Abstract] [Full Text] [PDF]

				J. Chen, J. A. Bander, T. A. Santore, Y. Chen, P. T. Ram, M. J. Smit, and R. Iyengar Expression of Q227L-Galpha s in MCF-7 human breast cancer cells inhibits tumorigenesis PNAS, March 3, 1998; 95(5): 2648 - 2652. [Abstract] [Full Text] [PDF]

				W. L. Lowe Jr., R. Fu, and M. Banko Growth Factor-Induced Transcription via the Serum Response Element Is Inhibited by Cyclic Adenosine 3',5'-Monophosphate in MCF-7 Breast Cancer Cells Endocrinology, June 1, 1997; 138(6): 2219 - 2226. [Abstract] [Full Text] [PDF]